Do’s and Don’ts” for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?
Intra-arterial chemotherapy (IAC) has emerged as the primary treatment option for retinoblastoma management. It enables the localized delivery of a higher concentration of chemotherapeutic agents (melphalan, carboplatin and topotecan) in the ophthalmic artery, enhancing tumour control and potentiall...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer Medknow Publications
2025-06-01
|
| Serie: | Indian Journal of Ophthalmology |
| Soggetti: | |
| Accesso online: | https://journals.lww.com/10.4103/IJO.IJO_2912_24 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|